SE0302794D0 - Novel microparticles for ultrasound contrast imaging and drug delivery - Google Patents

Novel microparticles for ultrasound contrast imaging and drug delivery

Info

Publication number
SE0302794D0
SE0302794D0 SE0302794A SE0302794A SE0302794D0 SE 0302794 D0 SE0302794 D0 SE 0302794D0 SE 0302794 A SE0302794 A SE 0302794A SE 0302794 A SE0302794 A SE 0302794A SE 0302794 D0 SE0302794 D0 SE 0302794D0
Authority
SE
Sweden
Prior art keywords
drug delivery
ultrasound contrast
contrast imaging
novel microparticles
microparticles
Prior art date
Application number
SE0302794A
Other languages
Swedish (sv)
Inventor
Per Hansson
Bjoern Lindman
Original Assignee
Per Hansson
Bjoern Lindman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Per Hansson, Bjoern Lindman filed Critical Per Hansson
Priority to SE0302794A priority Critical patent/SE0302794D0/en
Publication of SE0302794D0 publication Critical patent/SE0302794D0/en

Links

Abstract

The invention relates to a new method for producing stable microparticles, microcapsules and microbubbles possessing a core and shell structure, and the product(s) thereof. Said products are suitable for use as ultrasound contrast agent(s), drug delivery vehicles, and combined drug vehicles/ultrasound contrast agents for in-situ drug delivery.
SE0302794A 2003-10-24 2003-10-24 Novel microparticles for ultrasound contrast imaging and drug delivery SE0302794D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0302794A SE0302794D0 (en) 2003-10-24 2003-10-24 Novel microparticles for ultrasound contrast imaging and drug delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302794A SE0302794D0 (en) 2003-10-24 2003-10-24 Novel microparticles for ultrasound contrast imaging and drug delivery
PCT/SE2004/001546 WO2005039750A1 (en) 2003-10-24 2004-10-25 Novel microparticles for ultrasound contrast imaging and drug delivery

Publications (1)

Publication Number Publication Date
SE0302794D0 true SE0302794D0 (en) 2003-10-24

Family

ID=29546610

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302794A SE0302794D0 (en) 2003-10-24 2003-10-24 Novel microparticles for ultrasound contrast imaging and drug delivery

Country Status (2)

Country Link
SE (1) SE0302794D0 (en)
WO (1) WO2005039750A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2037999B1 (en) 2006-07-07 2016-12-28 Proteus Digital Health, Inc. Smart parenteral administration system
SG144763A1 (en) * 2007-01-24 2008-08-28 Univ Singapore Reverse phase layer-by-layer encapsulation of highly water soluble materials
EP2211974A4 (en) 2007-10-25 2013-02-27 Proteus Digital Health Inc Fluid transfer port information system
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
CN102946798A (en) 2010-02-01 2013-02-27 普罗秋斯数字健康公司 Data gathering system
WO2011094608A2 (en) 2010-02-01 2011-08-04 Proteus Biomedical, Inc. Two-wrist data gathering system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1539672A (en) * 1976-03-22 1979-01-31 Lloyds Bank California Aqueous multiphase dispersions and preparation thereof
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US5562099A (en) * 1990-10-05 1996-10-08 Massachusetts Institute Of Technology Polymeric microparticles containing agents for imaging
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
DE59409568D1 (en) * 1993-09-09 2000-11-30 Schering Ag Active ingredients and gas-containing microparticles
US5320812A (en) * 1993-10-04 1994-06-14 Becton, Dickinson And Company Clot activating polyelectrolyte complex and blood collection assembly containing same
AT433747T (en) * 1998-03-19 2009-07-15 Max Planck Gesellschaft A method for applying multiple layers of coating substances to template particles
DE19925311B4 (en) * 1999-05-27 2004-06-09 Schering Ag Multi-stage process for the production of gas-filled microcapsules
AU8665101A (en) * 2000-08-22 2002-03-04 Purdue Research Foundation Microparticle composition and method
DE10065068A1 (en) * 2000-12-21 2002-07-04 Schering Ag Multi-stage process for the production of gas-filled microcapsules having a narrow size distribution defined by defined external gassing during the microcapsule structure
JP2002226599A (en) * 2001-02-05 2002-08-14 Sanyo Chem Ind Ltd Method for producing water-absorbing resin
FR2839658B1 (en) * 2002-05-17 2004-08-06 Protex New microcapsule preparation process using gelatine containing a hydrophobic liquid and microcapsules obtained

Also Published As

Publication number Publication date
WO2005039750A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
RU2460732C2 (en) 2-aza-bicyclo[3,1,0]hexane derivatives as orexin receptor antagonists
RU2354656C2 (en) Spirocyclic cyclohexane derivatives
DE60336149D1 (en) Crosslinking agent having high reactivity and solubility, and their use in the preparation of conjugates for the targeted delivery of small molecule drugs
NL1026829A1 (en) Modified human IGF-1R antibodies.
NO20052285D0 (en) Solid particulate antifungal preparations for pharmaceutical use
DK1587789T3 (en) Selective serotomin - 2A / 2C - receptor - inverse - agonists as therapeutic agents for neurodegenerative diseases
NL1027596A1 (en) Stationary computed tomography system and method.
DE60307336D1 (en) Plunger for nanostructures
DE60239868D1 (en) Reservoir device for intraocular drug delivery
DK2258401T3 (en) Folate receptor targeted imaging agents
BRPI0014652B1 (en) manufacturing conjugates polyglutamate-therapeutic agent
NO20041315A (en) Drug Delivery System
CY1108532T1 (en) COMPOUNDS COMPOSITIONS and for providing the active agent
RU2006131132A (en) 1,3,5, -trizameschennye derivatives of 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
NL1014626A1 (en) Structure for CT system.
NL300887I2 (en) Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, in particular tofacitinibcitraat
NL1026329A1 (en) 2-Amino-pyridine derivatives useful for the treatment of diseases.
EA200501430A1 (en) Cannabinoid receptor ligands and their use
SE529087C8 (en) System for wireless generating ECG leads standard
NO20054072D0 (en) Therapeutic agent for spinal cord injury comprising interleukin-6 antagonist.
AT448323T (en) Soluble hyaluronidase glycoprotein (shasegp), process for its production, uses and pharmaceutical compositions containing
SE0100568D0 (en) Compounds
RU2004130280A (en) Substituted indazoles having pritovorakovoy activity
NO20002217D0 (en) Cyclopentane heptanoic acid, 2-heteroarylalkenylderivater as therapeutic agents
EA200501222A1 (en) Digidropteridinony, process for their preparation and their use as medicaments